ERBB2 and ductal breast carcinoma in situ: In addition, studies have revealed that senescent CAFs are present in multiple breast cancer subtypes, including HER2+, ER+ and triple-negative breast cancers, as well as ductal carcinoma in situ (DCIS) (16).